Skip to main content
. 2017 May 10;130(3):340–347. doi: 10.1182/blood-2016-12-755017

Table 3.

Targeted massively parallel sequencing of maternal plasma DNA for detection of F8 int22h-related inversions

Plasma sample Raw reads, M Mapped reads, M No. of reads/ on target, M No. of reads/ off target, M Coverage, %* PCR duplication rate, % Sequencing depth per base, -fold No. of SNPs in CEN region No. of RHDO classifications in CEN region No. of SNPs in TEL region No. of RHDO classifications in TEL region RHDO analysis Fetal status§
16A 161.8 153.8 147.1 16.8 99.96 70.4 129.2 15 4 1 0 Affected Affected
16B 70.6 67.2 65.0 7.8 99.67 39.7 130.6 13 5 1 0 Affected
17A 172.0 163.3 158.4 17.8 99.67 63.7 177.1 20 4 1 1 Unaffected Unaffected
18A 75.0 71.5 68.7 8.6 99.66 39.9 135.6 19 9 0 0 Affected Affected
18B 130.0 123.1 117.4 15.8 99.67 52.1 174.4 22 21 0 0 Affected

CEN, centromeric region; RHDO, relative haplotype dosage; TEL, telomeric region.

*

Coverage corresponds to the length of the covered nucleotides in the targeted region divided by the length of the targeted region.

PCR duplication rate corresponds to the proportion of PE reads with the same sequences and start-end coordinates.

Sequencing depth per base is defined as the sum of the bases sequenced within the targeted region divided by the length of the targeted region.

CEN corresponds to the region located up to 7 Mb downstream from the int22h-1 homolog in the direction of the F8 gene transcription start site (chrX: 147,109,089-154,109,089). TEL corresponds to a telomeric region spanning a 577-kb region downstream from the int22h-3 and covering chrX: 154,693,870-155,270,560.

§

Hemophilia status of the newborn was determined from the cord blood sample based on the factor VIII and factor IX assays, as appropriate.